Mriganka Sur

Sur and Sahin propose that biomarkers are crucial for future ASD studies

[Source:, October 15, 2015]   Today in Science magazine, Harvard neurologist Mustafa Sahin and MIT brain scientist Mriganka Sur summarize scientific progress toward delivering precision treatments for autism spectrum disorder (ASD). “Given the large number of genes that potentially confer ASD risk, the genetic heterogeneity of ASD presents a substantial obstacle to development […]